Episode Details

Send us Fan Mail

Cancer news can feel like a nonstop parade of miracle cures, but the lived reality is messier, harder, and far more human. We sit down with Dr. Robert Hoffman to talk about what it means to find an oncologist who won’t emotionally check out, won’t rush you onto a conveyor belt of protocols, and will fight to keep you from relapsing. That leads us straight to Dr. Tom Song’s unusual mix of intensity, independence, and patient level care, including how he navigates insurance so treatments like Keytruda can continue when other systems would stop.

We also zoom out to the tools patients can use to regain control. Joe shares why he went to Japan for a methionine PET scan and how functional imaging that tracks abnormal methionine uptake can answer a question standard CTs, MRIs, and blood tests often cannot: is there active disease right now? From keeping copies of every scan to showing up prepared, we make the case that self advocacy is not optional, especially when decisions carry lifelong side effects.

Then we tackle research hype head on through a real example: the heavily promoted pancreatic cancer pill (daraxonrasib). Dr. Hoffman walks through how he reads the original New England Journal of Medicine paper, why overall survival can look “beautiful” while progression free survival tells a harsher truth, and how side effects like rash can be minimized in summaries but brutal in real life. We also discuss the RAS gold rush, me too drug development, and why “cure” is the wrong word for most cancers compared to control, management, and staying ahead of recurrence.

If you know someone facing cancer, share this conversation, subscribe, and leave a review so more people can find it. What’s one cancer headline you want us to sanity check next?

Intro for podcast

information about subscriptions

Support the show

Support for Joe's Cure

Here is the link for Sunday's 4 pm Pacific time Zoom meeting